5-phosphoribosyl-I-pyrophosphate ( PRPP)
-The metabolic inter-relations of de novo purine biosynthesis and the purine interconversion reactions. The broken arrow between 5-phosphoribosyl-l-amine and inosinic acid represents a series ofbiochemical reactions whereby the purine ring is built up. The enzymes which are particularly important with respect to the present work are as follows. 1, phosphoribosylpyrophosphate amidotransferase (EC 2.4.2.14); 2, hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (EC 2.4.2.8); 3, adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7); 4, AMP aminohydrolase (EC 3.5.4.6).
Phosphoribosylpyrophosphate amidotransferase, which catalyses the first specific step on the de novo purine biosynthetic pathway, is subject to feedback inhibition by IMP, GMP, and AMP (Seegmiller et al., 1967; Caskey, Ashton, and Wyngaarden, 1964; Holmes et al., 1973) .
or the increased CSF levels of hypoxanthine and xanthine which occur in the syndrome cause the neurological disorder. It seems more likely that they are due to lack of GMP, though the existence of an unidentified toxic factor cannot be positively excluded. Exogenous adenine could at least in theory be used for GMP synthesis because AMP: pyrophosphate phosphoribosyltransferase (EC 2.4.2.7) (adenine phosphoribosyltransferase or APRT) activity is present and increased in the patients and the metabolic pathways through inosinic and xanthylic acids (IMP and XMP) are available ( Fig. 1 ). This idea received some support from the observations of Van der Zee, Schretlen, and Monnens (1968) who showed that the megaloblastic anaemia which exists in some cases of the Lesch-Nyhan syndrome can be cured by giving adenine. Felix and De Mars (1969) also showed that either additional adenine or high concentrations of folate were needed for the growth of fibroblasts from patients with the Lesch-Nyhan syndrome. It is of interest that Lommen et al. (1971) found normal erythrocyte GTP levels but low AMP, ADP, and ATP in 2 cases of the Lesch-Nyhan syndrome.
Oral adenine administration restored the adenine nucleotide concentration to normal and increased the GTP level slightly in their studies. The renal complications and gout can be prevented by giving allopurinol, but this has no effect on the neurological manifestations even when it is given from birth. Attempts to counteract the disordered purine metabolism by giving AMP, GMP, guanosine, 2,6-diaminopurine, and adenine orally have produced no improvement, even though in one study (Schulman et al., 1971 ) adenine and allopurinol administration was begun immediately after birth. Orotic acid, which was given in an attempt to deplete the pool of 5'-phosphoribosylpyrophosphate (PRPP) available for the first specific step (Fig. 1) on the purine biosynthetic pathway (Seegmiller, 1968) , also had no effect. The observation that glutamate produced some physical and neurological improvement (Ghadimi, 1969; Ghadimi, Bhalla, and Kirchenbaum, 1970) has not been substantiated except in so far as it was associated with improved nursing and general nutrition (Nyhan, 1972 (Subak-Sharpe, 1969 ) is at least a theoretical possibility. Erythrocytes transport purines from the tissues where they are synthesized to their sites of utilization, and the purine phosphoribosyltransferases effect the uptake of purines by these cells (Murray, 1971; Sperling et al., 1971; Adams and Harkness, 1973 The child sucked normally, was breast fed for 2 to 3 weeks and gained weight normally. He smiled at 6 to 7 weeks, and he recognized his mother at 6 weeks.
He could lift his head in the prone position at 3 months but severe motor retardation was apparent by 6 months and he has never been able to lift or support his trunk on outstretched hands. He has never crawled, walked, or been able to sit unsupported. He handled objects bimanually for the first time at 3 years and began to reach for things 3 months later. Choreoathetosis began at 12 months and, though of variable intensity, had progressively worsened to affect all four limbs. Opisthotonos was first observed at 9 months, and may occur during sleep. Spasticity of the legs, which was apparent at 2 years, improved with physiotherapy. He first vocalized at 6 months but his speech has always been slurred and his vocabulary poor.
At 18 months chronic ulcers on the buccal surface of his lips were the first sign of self inflicted trauma by biting. He also bit his fingers and this symptom with its attendant agitation and anxiety was relieved by bandaging his hands, but persistent lip biting has required total dental extraction. The lips have healed with minimal scarring, but he occasionally beats his head against objects or picks his nose until it bleeds, showing a persistent urge to self mutilation.
Past medical history. Bronchitis and measles without encephalitis. Tracheal stenosis was noted when he was anaesthetized for dental extraction.
Family history. The family pedigree is shown in Fig. 2 . There is no history suggestive of gout, urolithiasis, or neuropsychiatric illness in any of the members, and no evidence for transmission of the mutant X-linked gene through female relatives on the maternal side. The uric acid and PRT activities for the immediate blood relations are shown in Table I . Examination (at 3 years 5 months). A small, generally underdeveloped boy. Weight 10 kg (Fig. 3 Blood pressure was 100/60 mmHg. Glycosuria and proteinuria were absent. Haemoglobin 13-3 g/100 ml, erythrocyte indices normal, total leucocyte count 8200/mm', differential leucocyte count normal, serum uric acid 536 umol/l. (9 0 mg/100 ml), blood urea 5-43 zmol/l. (32 mg/100 ml), serum sodium 139 mmol/l., potassium 5-1 mmol/l., chloride 106 mmol/l., bicarbonate 21 mmol/l., calcium 2 * 39 mmol/l., phosphate 1 47 mmol/l., plasma total protein 70 g/l., albumin 47 g/l., total globulin 23 g/l., urinary uric acid 1 1 9.4 mmol/l. (160 mg/100 ml), uric acid/creatinine ratio 3-2 (normal range 0 4-1 -7 at age 4 years, Kaufman, 4 5 6 7
Greene, and Seegmiller, 1968 (Liddle, Seegmiller, and Laster, 1959) , creatinine (Bonsnes and Taussky, 1945) , protein (Lowry et al., 1951) ; 2,8-dioxyadenine (Schulman et al., 1971) ; the purine phosphoribosyltransferases (HGPRT and APRT) (Seegmiller et al., 1967) . Results The changes in the HGPRT and APRT levels which were associated with the exchange blood transfusion are shown together with blood and urine uric acid levels in Fig. 5 and ward observation were not detectably improved. Similarly, the pattern of compulsive behaviour and overall intelligence as judged clinically and psychometrically were not improved specifically in relation to the transfusion. Plasma and urine uric acid concentrations, and urine 2,8-dioxyadenine levels during allopurinol and adenine treatment are shown in Fig. 6 . There were no striking changes in the patient's behaviour during this period.
Neither tetrabenazine (5 mg twice daily for 1 month) nor thiopropazate (1 25 mg daily for 1 month) had any effect on the involuntary movements or behaviour. Chlorpromazine (5 mg three times daily for several months) produced an overall depression of activity with drowsiness.
Discussion
The clinical features of this case conform to those described by Lesch and Nyhan (1964) , and to the cases which have been reported by other workers (Kelley and Wyngaarden, 1972) . The present case appears to have been hypotonic from birth, a feature which has not usually been reported in the LeschNyhan syndrome (Nyhan, 1973) . Hypotonia in infancy may be due to a variety of causes (Dubowitz, 1969; Griffiths, 1973) . It frequently precedes the choreoathetotic forms of cerebral palsy caused by kernicterus or by severe anoxia in the perinatal period (often in term infants). Such children show a wide range of intelligence, though their choreoathetosis is never associated with the self mutilation characteristic of the Lesch-Nyhan syndrome. Prechtl (1971) emphasized the importance of cerebral maturation in the development of early motor skills. It is also clear that early interference with motor function may limit a child's development in a manner disproportionate to the degree of intellectual impairment. In a child with the Lesch-Nyhan syndrome the urge to self mutilation also impairs his ability to respond to stimuli from the environment, and in our patient the improved response after the final dental extraction was striking. The development of choreoathetosis in the present case did not differ substantially from the progression seen in children with cerebral palsy and it was the self mutilation and lack of any perinatal factors in the history which suggested the diagnosis.
The last trimester of pregnancy and the first 18 months of postnatal life are the periods during which the human brain is most vulnerable to factors (e.g. nutritional and endocrine deficiencies) which impair growth, this being unrelated to teratogenic susceptibility (Dobbing, 1972) . Nervous tissue, like bone marrow, depends largely on the purine salvage pathway as opposed to the de novo synthesis pathway (Fig. 1) for purine ribonucleotide synthesis (Lajtha and Vane, 1958; Howard, Kerson, and Appel, 1970) . Besides catalysing the direct formation of IMP and GMP for intracellular functions, HGPRT regulates the rate of purine uptake by cells (Berlin and Stadtman, 1966; Gots, 1971) and is needed for the transport of purines by erythrocytes (Murray, 1971; Sperling et al., 1971; Adams and Harkness, 1973) . Thus, congenital HGPRT deficiency may reduce intracellular GMP to levels which are rate-limiting for protein or nucleic acid synthesis at a time when this is critical for the rapid division and maturation of brain cells. The reported differences in the HGPRT activities in different regions of the brain are small, and need not necessarily reflect different enzyme activities within neurones or neuroglia. The largest difference, which is that seen between basal ganglia and the cerebral cortex is only twofold (Kelley et al., 1969) . This apparent difference may be further diminished when account is taken of the 5' nucleotidase (5' ribonucleotide phosphohydrolase EC 3.1.3.5) activity in different parts of the brain (Adams et al., 1971; Adams, 1973) . Factors other than the absolute levels of HGPRT may be important in determining the evolution of brain damage in the Lesch-Nyhan syndrome. Regional differences in, for example, the rate of neuronal development and biochemical differentiation during prenatal and early postnatal life, with earlier dependence on purine salvage pathways in the basal ganglia may influence the final pattern of brain damage.
Patients with partial deficiency of HGPRT have between about 0 05 and 10% of the normal level of enzyme in erythrocytes, gross hyperuricaemia, hyperuric aciduria, gout, uric acid, and urate nephropathies, with at the most, only minor neuropsychiatric damage (Kelley et al., 1969) . Increasing the present patient's circulating level of HGPRT to well above the range of values quoted by Kelley et al. (1969) did not influence the neuropsychiatric state and produced only a transient small decrease in the plasma urate concentration (Fig. 4) . This is compatible with the observations of Emmerson and Thompson (1973) that the clinical severity over the whole spectrum of neurological disability did not parallel the degree of erythrocyte HGPRT deficiency.
The absence of any observable effect on the neurological signs may reflect irreversible perinatal brain damage, and examination of the brains of older children has shown microcephaly and minor histological changes (Crome and Stern, 1972 ). It appears that though motor functions may already be 700 group.bmj.com on June 22, 2017 -Published by http://adc.bmj.com/ Downloaded from impaired at birth, significant cognitive development can still be expected. An intelligent athetoid child can often be trained to overcome his disabilities and to use mechanical aids, whereas much less can be accomplished with the mentally retarded disabled patient. Thus, every effort should be made to exploit the apparent differential impairment of intellectual and motor manifestations in the Lesch-Nyhan syndrome with as full an educational programme as the patient's physical disabilities allow.
It has been widely accepted that the high rate of purine biosynthesis in the Lesch-Nyhan syndrome is due to decreased feedback inhibition by GMP and/or IMP of the first specific reaction on the pathway of de novo purine biosynthesis (Seegmiller et al., 1967) . This hypothesis is not amenable to direct experimental proof in vivo though the kinetic properties in vitro of the relevant enzyme* isolated from human placenta are compatible with this suggestion (Holmes et al., 1973) . If the proposition of Seegmiller et al. (1967) is correct, our failure to influence uric acid levels in the blood and urine by transfusion with normal red cells must be due to one or more of the following factors. (i) The inability to introduce enough normal enzyme to increase the supply of GMP and/or IMP significantly; (ii) failure of GMP and/or IMP to cross cell membranes and reach the phosphoribosylpyrophosphate amidotransferase; (iii) an absolute requirement for HGPRT within recipient tissue cells to effect purine uptake and to catalyse the synthesis of GMP and IMP in a co-ordinated manner, as part of a single integrated cellular function. Similar considerations could apply to our failure to alter neuronal function.
The possible importance of an unidentified toxic factor in the aetiology of the Lesch-Nyhan syndrome has been stressed (Nyhan, 1973 Our results with adenine and allopurinol therapy are the same as those of most other investigators. Adenine has now been tried unsuccessfully in several centres (Van Der Zee et al., 1970; Schulman, et al., 1971 ; and the present study) and in the absence of any clear effect on the neurological state, its use is not recommended except for the treatment of the megaloblastic anaemia. Conversely, Demus, Kaiser, and Schaub (1973) thought that their patient was improved by adenine, but they were unable to continue giving it because of nephrotoxicity. The latter is due to the xanthine oxidase-catalysed oxidation of adenine to 2,8-dioxyadenine and can be avoided by giving allopurinol simultaneously with the adenine, as in the present work.
Our attempts to ameliorate choreoathetosis with tetrabenazine, thiopropazate, and chlorpromazine were unsuccessful, and these drugs cannot be recommended as having any specific role in the management of patients with the Lesch-Nyhan syndrome. Conversely, it is essential to give allopurinol in order to protect the urinary tract and to prevent the development of gout.
It is of interest that Bakay and Nyhan (1972) found that the variant type of HGPRT enzyme which is associated with the Lesch-Nyhan syndrome is activated by the normal enzyme in vitro. The present results show that this cannot be achieved when the two proteins are in separate and noncontiguous cells. New lines of treatment may stem from the recent evidence that erythrocytes from patients with the Lesch-Nyhan syndrome contain normal amounts of HGPRT protein, which is, however, abnormally labile in vivo. Thus, if the enzyme could be stabilized, its activity might be restored (Arnold, Meade, and Kelley, 1972) . The present work suggests that it would be necessary to stabilize the enzyme in the tissues generally and not only in the blood.
